Literature DB >> 19762425

Akt-dependent Pp2a activity is required for epidermal barrier formation during late embryonic development.

Ryan F L O'Shaughnessy1, Jonathan C Welti, Katherine Sully, Carolyn Byrne.   

Abstract

Acquisition of epidermal barrier function occurs late in mouse gestation. Several days before birth a wave of barrier acquisition sweeps across murine fetal skin, converging on dorsal and ventral midlines. We investigated the molecular pathways active during epidermal barrier formation. Akt signaling increased as the barrier wave crossed epidermis and Jun was transiently dephosphorylated. Inhibitor experiments on embryonic explants showed that the dephosphorylation of Jun was dependent on both Akt and protein phosphatase 2A (Pp2a). Inhibition of Pp2a and Akt signaling also caused defects in epidermal barrier formation. These data are compatible with a model for developmental barrier acquisition mediated by Pp2a regulation of Jun dephosphorylation, downstream of Akt signaling. Support for this model was provided by siRNA-mediated knockdown of Ppp2r2a (Pr55alpha or B55alpha), a regulatory subunit of Pp2a expressed in an Akt-dependent manner in epidermis during barrier formation. Ppp2r2a reduction caused significant increase in Jun phosphorylation and interfered with the acquisition of barrier function, with barrier acquisition being restored by inhibition of Jun phosphorylation. Our data provide strong evidence that Ppp2r2a is a regulatory subunit of Pp2a that targets this phosphatase to Jun, and that Pp2a action is necessary for barrier formation. We therefore describe a novel Akt-dependent Pp2a activity that acts at least partly through Jun to affect initial barrier formation during late embryonic epidermal development.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19762425      PMCID: PMC2752394          DOI: 10.1242/dev.037010

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  38 in total

Review 1.  Coordination and communication between the p53 and IGF-1-AKT-TOR signal transduction pathways.

Authors:  Arnold J Levine; Zhaohui Feng; Tak W Mak; Han You; Shengkan Jin
Journal:  Genes Dev       Date:  2006-02-01       Impact factor: 11.361

2.  Development of ichthyosiform skin compensates for defective permeability barrier function in mice lacking transglutaminase 1.

Authors:  Nobuo Kuramoto; Toshihiro Takizawa; Takami Takizawa; Masato Matsuki; Hiroyuki Morioka; John M Robinson; Kiyofumi Yamanishi
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

3.  Suppression of Akt signaling induces Fas ligand expression: involvement of caspase and Jun kinase activation in Akt-mediated Fas ligand regulation.

Authors:  Toshimitsu Suhara; Hyo-Soo Kim; Lorrie A Kirshenbaum; Kenneth Walsh
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

Review 4.  Transcription factor activation in response to cutaneous injury: role of AP-1 in reepithelialization.

Authors:  Samantha Yates; Timothy E Rayner
Journal:  Wound Repair Regen       Date:  2002 Jan-Feb       Impact factor: 3.617

5.  The serine/threonine phosphatase, PP2A: endogenous regulator of inflammatory cell signaling.

Authors:  T P Shanley; N Vasi; A Denenberg; H R Wong
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

6.  AKT-dependent HspB1 (Hsp27) activity in epidermal differentiation.

Authors:  Ryan F L O'Shaughnessy; Jonathan C Welti; James C Cooke; Ariel A Avilion; Bobby Monks; Morris J Birnbaum; Carolyn Byrne
Journal:  J Biol Chem       Date:  2007-04-17       Impact factor: 5.157

7.  Novel PI analogues selectively block activation of the pro-survival serine/threonine kinase Akt.

Authors:  Alan P Kozikowski; Haiying Sun; John Brognard; Phillip A Dennis
Journal:  J Am Chem Soc       Date:  2003-02-05       Impact factor: 15.419

8.  AKT1 provides an essential survival signal required for differentiation and stratification of primary human keratinocytes.

Authors:  Barry R Thrash; Craig W Menges; Robert H Pierce; Dennis J McCance
Journal:  J Biol Chem       Date:  2006-03-03       Impact factor: 5.157

9.  Keratinocyte-specific Pten deficiency results in epidermal hyperplasia, accelerated hair follicle morphogenesis and tumor formation.

Authors:  Akira Suzuki; Satoshi Itami; Minako Ohishi; Koichi Hamada; Tae Inoue; Nobuyasu Komazawa; Haruki Senoo; Takehiko Sasaki; Junji Takeda; Motomu Manabe; Tak Wah Mak; Toru Nakano
Journal:  Cancer Res       Date:  2003-02-01       Impact factor: 12.701

10.  A role for protein phosphatase-2A in p38 mitogen-activated protein kinase-mediated regulation of the c-Jun NH(2)-terminal kinase pathway in human neutrophils.

Authors:  Natalie J Avdi; Kenneth C Malcolm; Jerry A Nick; G Scott Worthen
Journal:  J Biol Chem       Date:  2002-08-16       Impact factor: 5.157

View more
  14 in total

1.  AKT1-mediated Lamin A/C degradation is required for nuclear degradation and normal epidermal terminal differentiation.

Authors:  A S Naeem; Y Zhu; W L Di; S Marmiroli; R F L O'Shaughnessy
Journal:  Cell Death Differ       Date:  2015-06-05       Impact factor: 15.828

Review 2.  Palatogenesis and cutaneous repair: A two-headed coin.

Authors:  Leah C Biggs; Steven L Goudy; Martine Dunnwald
Journal:  Dev Dyn       Date:  2014-11-25       Impact factor: 3.780

3.  A genetic variant in a PP2A regulatory subunit encoded by the PPP2R2B gene associates with altered breast cancer risk and recurrence.

Authors:  Alexei Vazquez; Diptee Kulkarni; Lukasz F Grochola; Gareth L Bond; Nicola Barnard; Deborah Toppmeyer; Arnold J Levine; Kim M Hirshfield
Journal:  Int J Cancer       Date:  2011-05-15       Impact factor: 7.396

4.  PPP2R2C loss promotes castration-resistance and is associated with increased prostate cancer-specific mortality.

Authors:  Eric G Bluemn; Elysia Sophie Spencer; Brigham Mecham; Ryan R Gordon; Ilsa Coleman; Daniel Lewinshtein; Elahe Mostaghel; Xiaotun Zhang; James Annis; Carla Grandori; Christopher Porter; Peter S Nelson
Journal:  Mol Cancer Res       Date:  2013-03-14       Impact factor: 5.852

5.  X-linked inhibitor of apoptosis protein (XIAP) regulation of cyclin D1 protein expression and cancer cell anchorage-independent growth via its E3 ligase-mediated protein phosphatase 2A/c-Jun axis.

Authors:  Zipeng Cao; Ruowen Zhang; Jingxia Li; Haishan Huang; Dongyun Zhang; Jingjie Zhang; Jimin Gao; Jingyuan Chen; Chuanshu Huang
Journal:  J Biol Chem       Date:  2013-05-29       Impact factor: 5.157

6.  Conditional PDK1 Ablation Promotes Epidermal and T-Cell-Mediated Dysfunctions Leading to Inflammatory Skin Disease.

Authors:  Minjun Yu; David M Owens; Sankar Ghosh; Donna L Farber
Journal:  J Invest Dermatol       Date:  2015-06-22       Impact factor: 8.551

7.  Active β-catenin is regulated by the PTEN/PI3 kinase pathway: a role for protein phosphatase PP2A.

Authors:  Amit Persad; Geetha Venkateswaran; Li Hao; Maria E Garcia; Jenny Yoon; Jaskiran Sidhu; Sujata Persad
Journal:  Genes Cancer       Date:  2016-11

8.  Tracing the dynamics of gene transcripts after organismal death.

Authors:  Alex E Pozhitkov; Rafik Neme; Tomislav Domazet-Lošo; Brian G Leroux; Shivani Soni; Diethard Tautz; Peter A Noble
Journal:  Open Biol       Date:  2017-01       Impact factor: 6.411

9.  Rab3Gap1 mediates exocytosis of Claudin-1 and tight junction formation during epidermal barrier acquisition.

Authors:  G Youssef; L Gerner; A S Naeem; O Ralph; M Ono; C A O'Neill; R F L O'Shaughnessy
Journal:  Dev Biol       Date:  2013-05-16       Impact factor: 3.582

10.  Smad4-dependent suppressor pituitary homeobox 2 promotes PPP2R2A-mediated inhibition of Akt pathway in pancreatic cancer.

Authors:  Qi Wang; Juanjuan Li; Wei Wu; Ruizhe Shen; He Jiang; Yuting Qian; Yanping Tang; Tingting Bai; Sheng Wu; Lumin Wei; Yi Zang; Ji Zhang; Lifu Wang
Journal:  Oncotarget       Date:  2016-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.